Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.2%

6 terminated/withdrawn out of 116 trials

Success Rate

93.5%

+7.0% vs industry average

Late-Stage Pipeline

9%

10 trials in Phase 3/4

Results Transparency

43%

37 of 87 completed trials have results

Key Signals

10 recruiting37 with results

Enrollment Performance

Analytics

Phase 1
54(50.0%)
N/A
21(19.4%)
Phase 2
21(19.4%)
Phase 4
7(6.5%)
Phase 3
3(2.8%)
Early Phase 1
2(1.9%)
108Total
Phase 1(54)
N/A(21)
Phase 2(21)
Phase 4(7)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (116)

Showing 20 of 116 trials
NCT07533136Not ApplicableNot Yet Recruiting

Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax

Role: lead

NCT06943404Phase 2Recruiting

BXCL501 After Stress to Increase Recovery Success

Role: collaborator

NCT07467707Phase 3Not Yet Recruiting

An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults

Role: collaborator

NCT07286955Not ApplicableRecruiting

Life Skills Training for Soldiers Arriving at Their First Duty Location

Role: collaborator

NCT05543993Completed

COVID Booster in Pregnancy and Lactation

Role: collaborator

NCT03882073Not ApplicableRecruiting

A Novel Approach to Upper Extremity Amputation to Augment Volitional Control and Restore Proprioception

Role: collaborator

NCT06205056Phase 1Recruiting

Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults

Role: collaborator

NCT04301154Phase 1Completed

Safety and Effects of Using Prime-boost HIVIS DNA and MVA-CMDR Vaccine Regimens With or Without Toll-like Receptor 4 Agonist on HIV Reservoirs in Perinatally HIV Infected Children and Youth

Role: collaborator

NCT06982183Phase 4Recruiting

The Effects of Propranolol, Hydrocortisone, and Morphine on Military-Relevant Performance Outcomes

Role: lead

NCT04784767Phase 1Completed

PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19

Role: collaborator

NCT02945501Not ApplicableRecruiting

Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency During NREM Sleep

Role: collaborator

NCT06824350Not ApplicableRecruiting

Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates

Role: collaborator

NCT04273841Not ApplicableTerminated

Impact of Sleep Deprivation and Caffeine in Medical Professionals

Role: lead

NCT05547880Completed

CNS Correlates of Extended Sleep Restriction

Role: lead

NCT04505501Phase 2Active Not Recruiting

Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection

Role: collaborator

NCT04273776Early Phase 1Active Not Recruiting

A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study

Role: lead

NCT04474015Not ApplicableEnrolling By Invitation

Optimizing Volunteer Comfort for Transcranial Electrical Stimulation (TES): An Assessment

Role: collaborator

NCT04826094Phase 1Completed

A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya

Role: collaborator

NCT05959616Phase 1Recruiting

Shigella Sonnei 53G Human Infection Study in Kenyan Adults

Role: collaborator

NCT02598388Phase 2Completed

Safety, Tolerability and Immunogenicity Study of 2-dose Heterologous Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo

Role: collaborator